CONDUIT PHARMACEUTICALS INC. Operating Lease, Right-of-Use Asset in USD from Q1 2024 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Conduit Pharmaceuticals Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2024 to Q3 2025.
  • Conduit Pharmaceuticals Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2025 was $194K, a 33.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)

CONDUIT PHARMACEUTICALS INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $194K -$98K -33.6% Sep 30, 2025 10-Q 2025-11-13
Q2 2025 $204K -$115K -36.1% Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $234K -$112K -32.4% Mar 31, 2025 10-Q/A 2025-08-14
Q4 2024 $263K Dec 31, 2024 10-Q 2025-11-13
Q3 2024 $292K Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $319K Jun 30, 2024 10-Q/A 2024-11-14
Q1 2024 $346K Mar 31, 2024 10-Q/A 2024-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.